Furthermore, the severity of skin rash during the treatment with anti-EGFR mo-Abs has been constantly reported as a predictive factor for response and survival [2], [16], and this was also the case in the present study, since the severity of skin rash was an independent predictive factor for TTP and OS. This evidence concerns the gene EGFR and Skin rash.